维普中文期刊产品整合服务
138篇 您的检索式:作者名="Granger K"
    题名 作者 年代 出处 被引量
1Factors affecting healing after arthroscopic rotator cuff repair显示文摘Rotator cuff repair has been shown to have good longterm results. Unfortunately, a significant proportion of repairs still fail to heal. Many factors, both patient and surgeon related, can influence healing after repair. Older age, larger tear size, worse muscle quality, greater muscle-tendon unit retraction, smoking, osteoporosis, diabetes and hypercholesterolemia have all shown to negatively influence tendon healing. Surgeon related factors that can influence healing include repair construct-single vs double row, rehabilitation, and biologics including platelet rich plasma and mesenchymalstem cells. Double-row repairs are biomechanically stronger and have better healing rates compared with single-row repairs although clinical outcomes are equivalent between both constructs. Slower, less aggressive rehabilitation programs have demonstrated improved healing with no negative effect on final range of motion and are therefore recommended after repair of most full thickness tears. Additionally no definitive evidence supports the use of platelet rich plasma or mesenchymal stem cells regarding improvement of healing rates and clinical outcomes. Further research is needed to identify effective biologically directed augmentations that will improve healing rates and clinical outcomes after rotator cuff repair.Amir M Abtahi Erin K Granger Robert Z Tashjian 2015World Journal of Orthopedics2015,6,2:16
2妊娠期高血压免疫因子、肿瘤坏死因子α、血管紧张素Ⅱ1型受体自身抗体对妊娠可溶性fms样酪氨酸1和可溶性Endoglin产物的影响显示文摘最近研究发现先兆子痫中血管新生因子、可溶性fms样酪氨酸激酶(sFlt-1)和可溶性Endoglin(sEn-doglin)不平衡;然而尚不清楚它们过度分泌的启动机制。方法:长期给予怀孕大鼠肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)或抗血管紧张素Ⅱ受体的自身抗体(AT1-AA),测定其循环和胎盘的sFlt-1和(或)sEndoglin以确定这些因素的免疫调节作用。Parrish MR Murphy SR Rutland S Wallace K Wenzel K Wallukat G Keiser S Ray LF Dechend R Martin JN Granger JP La Marca B 黄晓斌 2010中华高血压杂志2010,18,12:5
3Molecular determinants of shear rate-dependent leukocyte adhesion in postcapillary venules显示文摘BIENVENU K GRANGER D N 1993Am J Physiol1993,264,2:2
4Effects of candesartan on mortality and morbidity in patients with chronic heart failure, the charm - overall program显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,9379:1
5Effect of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,:1
6Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme 显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,:1
7Effects of candesartan on mortality and morbidity in patients with chronic heart failure:the CHARM-Overall programme显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,:1
8Outcomes in the first 5 years after traumatic brain injury显示文摘Corrigan JD Smith Knapp K Granger CV 1998Arch Phys Med Rehabil1998,79,:1
9Process of Cure of Ethylene Propylene Diene Monomer Rubbers Evaluation of State of Cure显示文摘Azaar K Lamine B Granger R 2000Plast Rubber Compos2000,29,:1
10Prolongation of renal allograft survival in a animal model by oral rapamycin monotherapy显示文摘Granger D K Cromwell J W Chen S C 1995Transplantation1995,59,2:1
11Effects of candesartan on mortality and morbidity in patient with chronic heart failure:the CHARM-Overall programme 显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,9386:1
12Effects of candesartan on Mortality and morbidity in patients with chronic heart failure: the CHARM - Overall programme 显示文摘Pfeffer MA Swedberg K Granger CB 2003The Lancet2003,362,9386:1
13The Reliability of the Functional Independence Measure:A Quantitative Review显示文摘Ottenbacher K J Hsu Y Granger C V 1996Arch Phys Med Rehabil1996,77,12:1
14Effects of candesartan on mortality and morbidity in patients with chronic heart failure:the CHARM-Overall programme显示文摘PFEFFER M A SWEDBERG K GRANGER C B 2003Lancet2003,362,9386:1
15Downregulation of TGFbetal mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous inmmunonglobulin显示文摘Amemiya K Semino M C Granger R P 2000Clin Immunol2000,94,2:1
16Effects of candesartan on mortality and morbidity in patients with chronic heart failure : The CHARM - Overall programme 显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,9386:1
17Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity-added显示文摘Swedberg K Pfeffer M Granger C 1999J Card Fail1999,5,:1
18Induction of heine oxygenase 1 attenu- ates placental ischemia-induced hypertension 显示文摘George EM Cockrell K Aranay M Csongradi E Stec DE Granger JP 2011Hyperten- sion2011,57,5:1
19Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme 显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,:1
20Effects of candesartan on mortaliy and morbidity in patients with heart failure the CHARM - overall pregramme显示文摘Pfeffer MA Swedberg K Granger CB 2003Lancet2003,362,:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费